MASI241220C170000
- 7.80
- +1.80+30.00%
Masimo Newsroom
Revenues Not Telling The Story For Masimo Corporation (NASDAQ:MASI) After Shares Rise 28%
Jefferies Keeps Their Hold Rating on Masimo (MASI)
Masimo Stock Soars to 52-week High, Hits $173.91
Breaking Down Masimo: 5 Analysts Share Their Views
Masimo Analyst Ratings
Stifel Maintains Masimo(MASI.US) With Buy Rating, Raises Target Price to $190
Stifel Nicolaus Remains a Buy on Masimo (MASI)
Express News | Masimo Corp : Stifel Raises Target Price to $190 From $170
Masimo Refocuses on Core Healthcare Operations
Express News | Masimo Corp - Terminates Executive Vice President Tao Levy
Masimo Appoints Michelle Brennan as Interim CEO
Correction to Masimo Terminates Founder Kiani as CEO on Oct. 29
Assessing MedTech Impact From Potential China Tariffs
Is There An Opportunity With Masimo Corporation's (NASDAQ:MASI) 44% Undervaluation?
Masimo Third Quarter 2024 Earnings: EPS Misses Expectations
4 Analysts Assess Masimo: What You Need To Know
Masimo's Q3 Earnings Rise Y/Y, Healthcare Demand Drives Growth
Masimo Stock Soars to 52-week High, Hits $173.9 Amid Robust Growth
Wells Fargo Maintains Masimo(MASI.US) With Buy Rating, Maintains Target Price $171
Piper Sandler Maintains Masimo(MASI.US) With Buy Rating, Raises Target Price to $180